Evaluation of a Tay-Sachs Disease screening program

Clinical Genetics

Volumn 63, Issue 5, 2003, Pages 386-392

  Gason, A A ^a   Sheffield, E ^b   Bankier, A ^a,b,c   Aitken, M A ^a,d   Metcalfe, S ^a,d,e   Stewart, K Barlow ^f   Delatycki, Martin B ^a,b,c,d,e  

^a MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d University of Melbourne   (Australia)

^e UNIVERSITY OF MELBOURNE   (Australia)

^f ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

Education; Genetics; Screening; Tay Sachs Diseases

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; AUSTRALIA; AWARENESS; BLOOD SAMPLING; CHEEK; COMMUNITY CARE; CONTROLLED STUDY; DNA DETERMINATION; EDUCATION; EMOTION; FEMALE; GENETIC COUNSELING; GENETIC SCREENING; HEALTH BEHAVIOR; HEALTH EDUCATION; HEALTH PROGRAM; HETEROZYGOTE DETECTION; HIGH SCHOOL; HUMAN; JEW; MALE; MEDICAL DECISION MAKING; PREDICTION; PRIORITY JOURNAL; SAMPLING; STUDENT; TAY SACHS DISEASE;

ADOLESCENT; ATTITUDE TO HEALTH; AUSTRALIA; FEMALE; GENETIC COUNSELING; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HETEROZYGOTE; HUMANS; JEWS; MALE; MASS SCREENING; PATIENT EDUCATION; QUESTIONNAIRES; TAY-SACHS DISEASE; TIME FACTORS;

EID: 0042029478     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0004.2003.00074.x     Document Type: Article

References (31)

1. 2 gangliosidoses. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Basis Of Inherited Disease, 7th edn. New York: McGraw-Hill, 1995: 2839-2879.
2. Okada S & O'Brien JS. Tay-Sachs disease: generalised absence of a β-D-N-acetyl-hexosaminidase component. Science 1969: 165: 698-700.
3. Sandhoff K. Variation of β-N-acetylhexosaminidase pattern in Tay-Sachs disease. FEBS Lett 1969: 4: 351-359.
4. Myerowitz R, Piekarz R, Neufeld EF, Shows TB, Suzuki K. Human β-hexosaminidase α chain: coding sequence and homology with the β-chain. Proc Natl Acad Sci USA 1985: 82: 7830-7834.
5. Myerowitz R & Costigan FC. The major defect in Ashkenazi Jews with Tay-Sachs disease is an insertion in the gene for the α-chain of β-hexosaminidase. J Biol Chem 1988: 263: 18587-18589.
6. Myerowitz R. Splice junction mutation in some Ashkenazi Jews with Tay-Sachs disease: evidence against a single defect within this ethnic group. Proc Natl Acad Sci USA 1988: 85: 3955-3959.
7. Navon R & Proia RL. The mutations in Ashkenazi Jews with adult GM2 gangliosidosis, the adult form of Tay-Sachs disease. Science 1989: 243: 1471-1474.
8. Kaback MM, Lim-Steele J, Dabholkar D et al. An international perspective, 1970-93. JAMA 1993: 270: 2307-2315.
9. Mitchell JJ, Capua A, Clow C, Scriver CR. Twenty-year outcome analysis of genetic screening programs for Tay-Sachs and β-Thalassemia disease carriers in high schools. Am J Hum Genet 1996: 59: 793-798.
10. Kaback MM, Nathan TJ, Greenwald S. Tay-Sachs disease: heterozygote screening and prenatal diagnosis. U.S. experience and world perspective. In: Kaback MM, ed. Tay-Sachs Disease, Screening and Prevention. New York: Alan R. Liss, 1997:13-36.
11. Broide E, Zeigler M, Ekstein J, Bach G. Screening for Tay-Sachs disease in the ultra-orthodox Ashkenazi Jewish community in Israel. Am J Med Genet 1993: 47: 213-215.
12. Natowicz MR. Heterozygote screening for Tay-Sachs Disease: past successes and future challenges. Curr Opin Paediatr 1996: 8: 625-629.
13. Kaback MM. Population-based genetic screening for reproductive counseling: The Tay-Sachs disease model. Eur J Pediatr 2000: 159 (Suppl. 3): S192-S195.
14. O'Brien J, Okada S, Chen D, Fillerup D. Tay-Sachs hexosaminidase assay. N Engl J Med 1990: 283: 15-20.
15. Fernandes MJ, Kaplan F, Clow CL, Hechtman P, Scriver CR. Specificity and sensitivity of hexosaminidase assays and DNA analysis for the detection of Tay-Sachs disease gene carriers among Ashkenazi Jews. Genet Epidemiol 1992: 9: 169-175.
16. Roberts L. One worked: the other didn't. Science 1990: 247: 17-19.
17. Barlow-Stewart K, Burnett L, Proos A et al. Development and evaluation of a genetics screening program for Tay-Sachs disease and cystic fibrosis for Australian Jewish high school students. J Med Genet, in press.
18. Burnett L, Proos AL, Chesher D et al. The Tay-Sachs disease prevention program in Australia: Sydney pilot study. Med J Aust 1995: 163: 298-300.
19. Jones J. Public perception of genetic testing. BMJ 1999: 319: 1283.
20. Struewing JP, Lerman C, Kase RG, Giambarresi TR, Tucker MA. Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families. Cancer Epidemiol Biomarkers Prev 1995: 4: 169-173.
21. Bach G, Tomczak J, Risch N, Ekstein J. Tay-Sachs screening in the Jewish Ashkenazi population: DNA testing is the preferred procedure. Am J Med Genet 2001: 99: 70-75.
22. Andrews LB, Fullarton JW, Holtzman NA, Motulksy AG, eds. Assessing Genetic Risks: Implications for Health and Social Policy. Washington, DC: National Academy Press, 1994.
23. Scriver CR. Review of assessing genetic risks: implications for health and social policy. Am J Hum Genet 1995: 56: 814-816.
24. Working Party of the Clinical Genetics Society (United Kingdom). The genetic testing of children. J Med Genet 1994: 31: 785-797.
25. Clow CL & Scriver CR. Knowledge about and attitudes toward genetic screening among high-school students: the Tay-Sachs experience. Pediatrics 1977: 59: 86-91.
26. Banet E & Ayuso E. Teaching genetics at secondary school: a strategy for teaching about the location of inheritance information. Sci Education 2000: 84: 313-351.
27. Bekker H, Modell M, Denniss G et al. Uptake of cystic fibrosis carrier testing in primary care: supply push or demand pull? BMJ 1993: 306: 1584-1586.
28. Quick KK. Reproductive decision making and medical genetics: An empirical study of individual decision processes. Diss Ab Intl: The Sciences and Engineering 1998: 58(9-B): 5153.
29. Middleton A, Hewison J, Mueller RF. Attitudes of deaf adults toward genetic testing for hereditary deafness. Am J Hum Genet 1998: 63: 1175-1180.
30. Wilkinson D. For whose benefit? Politics and sickle cell. Black Scholar 1974: 5: 29.
31. Marteau TM, Dormandy E, Michie S. A measure of informed choice. Health Expect 2001: 4: 99-108.